Tip:
Highlight text to annotate it
X
[MUSIC PLAYING]
At Georgia Tech, we are creating the next.
The next big idea, the next technology,
and the next group of innovators and entrepreneurs.
We're partnering on campus and around the world with business,
industry, and other Universities.
And in the US with government agencies
to develop solutions to some of society's most
pressing problems.
We are integrating microtechnology,
clinical medicine, and experimental hematology.
In our lab, we are creating the next generation
of diagnostic and medical devices
for childhood diseases and blood disorders.
Some of those products include the AnemoCheck, which
is a device in which patients can check their own anemia
at home, developed by Georgia Tech
alumnus and my former student, Erica Tyburski.
And also the CellScope Oto, which
is a device in which parents can check their children's
ear infections at home with a simple smartphone.
We've created the next technology
to administer vaccines around the world.
Working with Emory University and CDC,
we've developed microneedle patches
that will allow patients to painlessly self administer
the annual flu vaccine.
These patches will also allow health care workers
to bring polio, measles, and other lifesaving
vaccines more easily to children in developing countries.
We're developing the next generation of microbes
to convert the sugars in plant material
into high energy fuels and pharmaceuticals.
We're also working on reducing the time
it takes to engineer these microbes from years down
to days, so that in the future it
will be possible to produce a number of different chemicals
from biorenewals.